Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ADMA – Adma Biologics Inc

ADMA Biologics Inc
ADMA
$14.12
Name : ADMA Biologics Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $3,368,272,640.00
EPSttm : 0.85
finviz dynamic chart for ADMA
ADMA Biologics Inc
$14.12
0.89%
$0.125

Float Short %

6.83

Margin Of Safety %

14

Put/Call OI Ratio

0.37

EPS Next Q Diff

0.04

EPS Last/This Y

-0.29

EPS This/Next Y

0.37

Price

13.98

Target Price

32.33

Analyst Recom

1.5

Performance Q

-23.72

Relative Volume

1.23

Beta

0.4

Ticker: ADMA




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-09-08ADMA16.420.374.0987615
2025-09-09ADMA16.390.380.6888439
2025-09-10ADMA15.740.384.9390972
2025-09-11ADMA16.130.390.5291398
2025-09-12ADMA16.10.400.6991312
2025-09-15ADMA15.240.400.4291381
2025-09-16ADMA15.690.403.2592868
2025-09-17ADMA15.560.413072403534210.859560067681994519
2025-09-18ADMA16.170.410.4194243
2025-09-19ADMA15.920.411.4894517
2025-09-22ADMA16.030.350.1886024
2025-09-23ADMA15.980.355.2286524
2025-09-24ADMA15.670.370.1888150
2025-09-25ADMA15.310.370.6488237
2025-09-26ADMA15.610.370.0989074
2025-09-29ADMA14.70.361.5289376
2025-09-30ADMA14.650.363.2989332
2025-10-01ADMA15.060.350.1689705
2025-10-02ADMA14.540.370.0388790
2025-10-03ADMA14.650.372.2489036
2025-10-06ADMA14.060.380.9189657
2025-10-07ADMA13.980.371.2992475
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-09-08ADMA16.426.7- 0.56
2025-09-09ADMA16.386.7- 0.56
2025-09-10ADMA15.766.7- 0.56
2025-09-11ADMA16.116.7- 0.56
2025-09-12ADMA16.106.7- 0.56
2025-09-15ADMA15.306.7- 0.56
2025-09-16ADMA15.696.7- 0.56
2025-09-17ADMA15.586.7- 0.56
2025-09-18ADMA16.176.7- 0.56
2025-09-19ADMA15.906.7- 0.56
2025-09-22ADMA16.036.7- 0.56
2025-09-23ADMA15.966.7- 0.56
2025-09-24ADMA15.666.7- 0.56
2025-09-25ADMA15.326.7- 0.56
2025-09-26ADMA15.616.7- 0.56
2025-09-29ADMA14.706.7- 0.56
2025-09-30ADMA14.656.7- 0.56
2025-10-01ADMA15.056.7- 0.56
2025-10-02ADMA14.526.7- 0.56
2025-10-03ADMA14.656.7- 0.56
2025-10-06ADMA14.066.7- 0.56
2025-10-07ADMA13.986.7- 0.56
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-09-08ADMA-6.733.096.49
2025-09-09ADMA-6.733.096.49
2025-09-10ADMA-6.733.096.49
2025-09-11ADMA-6.733.096.50
2025-09-12ADMA-6.733.096.50
2025-09-15ADMA-6.733.076.50
2025-09-16ADMA-6.733.076.50
2025-09-17ADMA-6.953.076.50
2025-09-18ADMA-6.953.076.50
2025-09-19ADMA-6.953.076.50
2025-09-22ADMA-6.733.226.50
2025-09-23ADMA-6.733.226.50
2025-09-24ADMA-6.733.226.50
2025-09-25ADMA-6.733.226.83
2025-09-26ADMA-6.733.226.83
2025-09-29ADMA-6.733.216.83
2025-09-30ADMA-6.733.216.83
2025-10-01ADMA-6.733.216.83
2025-10-02ADMA-6.733.216.83
2025-10-03ADMA-6.733.216.83
2025-10-06ADMA-6.733.036.83
2025-10-07ADMA-6.733.036.83
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

0.14

Avg. EPS Est. Current Quarter

0.16

Avg. EPS Est. Next Quarter

0.18

Insider Transactions

-6.73

Institutional Transactions

3.03

Beta

0.4

Average Sales Estimate Current Quarter

131

Average Sales Estimate Next Quarter

137

Fair Value

15.93

Quality Score

99

Growth Score

79

Sentiment Score

19

Actual DrawDown %

45.5

Max Drawdown 5-Year %

-63.1

Target Price

32.33

P/E

16.47

Forward P/E

15.9

PEG

0.53

P/S

7.04

P/B

8.41

P/Free Cash Flow

50.76

EPS

0.85

Average EPS Est. Cur. Y​

0.56

EPS Next Y. (Est.)

0.93

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

44.06

Relative Volume

1.23

Return on Equity vs Sector %

27.3

Return on Equity vs Industry %

41

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

ADMA Biologics Inc
Sector: Healthcare
Industry: Biotechnology
Employees: 685
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
stock quote shares ADMA – Adma Biologics Inc Stock Price stock today
news today ADMA – Adma Biologics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADMA – Adma Biologics Inc yahoo finance google finance
stock history ADMA – Adma Biologics Inc invest stock market
stock prices ADMA premarket after hours
ticker ADMA fair value insiders trading